Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin controlled-release adjunctive therapy for partial onset seizures
2010-019035-35Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in epilepsy (2 arms), sponsored by Pfizer. Primary endpoint: Log-transformed 28-day partial seizure rate. Started Nov 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2010-019035-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019035-35.